Skip to main content
. Author manuscript; available in PMC: 2017 May 22.
Published in final edited form as: Int J Nanotechnol Nanomed. 2016 Oct 30;1(1):http://www.opastonline.com/wp-content/uploads/2016/10/nanoparticles-for-effective-combination-therapy-of-cancer-ijnn-16-003.pdf.

Figure 3.

Figure 3

PPM-DD–optimized ND-drug combinations. (A) A schematic model of the PPM experimental framework. Doxorubicin; Bleomycin; Mitoxantrone; Paclitaxel. (B) PPM-derived optimal ND-drug combinations (NDC) outperform a random sampling of NDCs in effective therapeutic windows of treatment of cancer cells compared to control cells. Reprinted with permission from H. Wang et al. [24] Copyright 2014 American Chemical Society.